# Askal Ayalew Ali

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/askal-ayalew-ali/

## Facts

| Field | Value |
| --- | --- |
| Citations | 548 |
| Field | Global Cancer Incidence and Screening |
| h-index | 13 |
| i10-index | 22 |
| Last Known Institution | Florida Agricultural and Mechanical University |
| OpenAlex ID | https://openalex.org/A5036504669 |
| ORCID iD | 0000-0002-0535-6300 |
| Works | 79 |

## Researcher papers

- [Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines](https://scholariq.org/papers/statins-utilization-trends-and-expenditures-in-the-u-s-before-and-after-the/)
- [Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States](https://scholariq.org/papers/cost-effectiveness-analysis-of-1st-through-3rd-line-sequential-targeted-therapy/)
- [Geographically-weighted regression analysis of percentage of late-stage prostate cancer diagnosis in Florida](https://scholariq.org/papers/geographically-weighted-regression-analysis-of-percentage-of-late-stage-prostate/)
- [Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes](https://scholariq.org/papers/machine-learning-algorithms-to-predict-major-adverse-cardiovascular-events-in/)
- [Value Assessment Frameworks in the United States: A Call for Patient Engagement](https://scholariq.org/papers/value-assessment-frameworks-in-the-united-states-a-call-for-patient-engagement/)
- [Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients](https://scholariq.org/papers/parameterization-of-a-disease-progression-simulation-model-for-sequentially/)
- [Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida](https://scholariq.org/papers/impact-of-comorbidities-on-prostate-cancer-stage-at-diagnosis-in-florida/)
- [Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial](https://scholariq.org/papers/using-quality-adjusted-progression-free-survival-as-an-outcome-measure-to-assess/)
- [Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives](https://scholariq.org/papers/economic-evaluation-of-sequencing-strategies-in-her2-positive-metastatic-breast/)
- [A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan](https://scholariq.org/papers/a-cost-effectiveness-analysis-of-trastuzumab-containing-treatment-sequences-for/)
- [Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer](https://scholariq.org/papers/comparative-cost-effectiveness-of-radiotherapy-among-older-women-with-hormone/)

## Researcher topics

- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Florida Agricultural and Mechanical University](https://scholariq.org/institutions/florida-agricultural-and-mechanical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.